<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02912611</url>
  </required_header>
  <id_info>
    <org_study_id>160610</org_study_id>
    <nct_id>NCT02912611</nct_id>
  </id_info>
  <brief_title>Detection and Management of Acute Kidney Injury (AKI) in Low and Low Middle Income Countries: A Pilot Feasibility Project</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Society of Nephrology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This feasibility study will be conducted at 4 international sites located in Asia (Dhahran,&#xD;
      Nepal); Africa (Blantyre, Malawi and Kilimanjaro, Tanzania) and Latin America (Cochabamba,&#xD;
      Bolivia).&#xD;
&#xD;
      Each site comprises a cluster (including 3-4 health centers - 1 district hospital - 1&#xD;
      regional referral hospital) that service the population around the site area. Patients&#xD;
      presenting at a health care clinic or hospital emergency department with signs and symptoms&#xD;
      associated with high and moderate risk of developing AKI will undergo a point of care (POC)&#xD;
      test to measure serum creatinine, saliva urea nitrogen dipstick (exclusively in Malawi), and&#xD;
      a urine dipstick test for color, protein, glucose, blood and specific gravity. Patients who&#xD;
      meet the study inclusion criteria will be approached for consent. Patients enrolled in the&#xD;
      study will be followed throughout the health care evaluation and tracked through their course&#xD;
      by location i.e. health care center, hospital, and home. Outcomes will be recorded through 6&#xD;
      months following the health care evaluation.&#xD;
&#xD;
      The protocol will have an initial observation phase, during which relevant healthcare staff&#xD;
      and the research team will be trained to identify patients at moderate or high risk of AKI&#xD;
      and use of the point of care (POC) test for serum creatinine, saliva urea nitrogen dipstick&#xD;
      (exclusively in Malawi), and urine dipstick test. During this phase patients will be tracked&#xD;
      throughout the health care evaluation, however the teleconsultation will not be implemented&#xD;
      and no specific guidance for managing the patient will be provided.&#xD;
&#xD;
      During the subsequent intervention phase, the research team will interact with the local&#xD;
      healthcare providers to and the teleconsultation physician, providing guidance on the&#xD;
      management of the patient based on a standardized protocol. Protocols for patient care will&#xD;
      be pre-specified, with minor adjustments to meet local requirements.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 1, 2016</start_date>
  <completion_date type="Actual">March 31, 2018</completion_date>
  <primary_completion_date type="Actual">September 29, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assess the feasibility of implementing an education and training program to optimize care of AKI</measure>
    <time_frame>1 year</time_frame>
    <description>Managment will be based on a protocol driven comprehensive 5R (Risk, Recognition, Response, Renal Support and Rehabilitation) approach in resource constrained regions in Africa, Asia and Latin America.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">2101</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>Moderate and High risk for AKI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Education and Protocol based management</intervention_name>
    <arm_group_label>Moderate and High risk for AKI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:Presence of Signs and Symptoms determining AKI risk&#xD;
&#xD;
          -  Decreased urine volume&#xD;
&#xD;
          -  Hypotension/ shock&#xD;
&#xD;
          -  Coma&#xD;
&#xD;
          -  Jaundice&#xD;
&#xD;
          -  Confusion&#xD;
&#xD;
          -  Dyspnea&#xD;
&#xD;
          -  Symptoms of respiratory infection&#xD;
&#xD;
          -  Petechia, ecchymosis, bleeding&#xD;
&#xD;
          -  Hypertension (in pregnancy)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic kidney disease in patients receiving regular dialysis treatment&#xD;
&#xD;
          -  Kidney transplant patients&#xD;
&#xD;
          -  Unable to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Obrero #2</name>
      <address>
        <city>Cochabamba</city>
        <country>Bolivia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Central Hospital (QECH)</name>
      <address>
        <city>Blantyre</city>
        <country>Malawi</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>BP Koirala Institute of Health Sciences</name>
      <address>
        <city>Dharān Bāzār</city>
        <state>Sansari District</state>
        <zip>56700</zip>
        <country>Nepal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bolivia</country>
    <country>Malawi</country>
    <country>Nepal</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>September 21, 2016</study_first_submitted>
  <study_first_submitted_qc>September 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2016</study_first_posted>
  <last_update_submitted>July 24, 2020</last_update_submitted>
  <last_update_submitted_qc>July 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Ravindra Mehta</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

